Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
In Diagnostics Inc. has 1 pending office action in the Semiconductors, Circuits & Optics technology area. This case is assigned to the distinct examiner AKBAR HASSAN RIZVI, who is the busiest examiner for the company. The matter is being prosecuted in 1 distinct art unit.
The company's strategy is focused on the specific requirements of this single examiner. Because there is only 1 pending action, the prosecution team can dedicate its resources to addressing the feedback provided by AKBAR HASSAN RIZVI within the 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RIZVI, AKBAR HASSAN | 1 | 88.1% | +14.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19088766 | CLINICAL SPECTROPHOTOMETER FOR GENERAL CHEMISTRY, IMMUNO-ASSAY AND NUCLEIC ACID DETECTION | RIZVI, AKBAR HASSAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19088766 | CLINICAL SPECTROPHOTOMETER FOR GENERAL CHEMISTRY, IMMUNO-ASSAY AND NUCLEIC ACID DETECTION | RIZVI, AKBAR HASSAN | — |
| Art Unit | Apps |
|---|---|
| 2877 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19088766 | CLINICAL SPECTROPHOTOMETER FOR GENERAL CHEMISTRY, IMMUNO-ASSAY AND NUCLEIC ACID DETECTION | RIZVI, AKBAR HASSAN | 2877 | DP | Non-Final OA | — | Pending | Mar 24, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIn Diagnostics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Akbar Hassan Rizvi has the most, with 1 of In Diagnostics Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
